Trial Profile
Phase I/ II trial with abraxane and trastuzumab for advanced/recurrent HER2-positive gastric cancer
Status:
Not yet recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 11 Nov 2013
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Trastuzumab (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 21 Sep 2013 New trial record